Stephen T. Sonis

Active 1978–2025

115
Papers
20,858
Citations
79
h-index
112
i10-index

Citations

Citations per year for Stephen T. Sonis1976: 1 citations1979: 1 citations1981: 2 citations1982: 2 citations1984: 2 citations1985: 4 citations1986: 1 citations1987: 4 citations1988: 4 citations1989: 1 citations1990: 5 citations1992: 6 citations1993: 3 citations1994: 4 citations1995: 7 citations1996: 13 citations1997: 9 citations1998: 28 citations1999: 30 citations2000: 30 citations2001: 53 citations2002: 30 citations2003: 91 citations2004: 98 citations2005: 95 citations2006: 162 citations2007: 134 citations2008: 122 citations2009: 99 citations2010: 104 citations2011: 136 citations2012: 112 citations2013: 146 citations2014: 182 citations2015: 141 citations2016: 151 citations2017: 147 citations2018: 107 citations2019: 671 citations2020: 614 citations2021: 621 citations2022: 365 citations2023: 311 citations2024: 506 citations2025: 223 citations1977–1978: no citations, so these years are not shown1980: no citations, so this year is not shown1983: no citations, so this year is not shown1991: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 984 citing papers, 24.9% of this breakdownChina: 365 citing papers, 9.2% of this breakdownBrazil: 234 citing papers, 5.9% of this breakdownAustralia: 202 citing papers, 5.1% of this breakdownUnited Kingdom: 182 citing papers, 4.6% of this breakdownItaly: 174 citing papers, 4.4% of this breakdownNetherlands: 151 citing papers, 3.8% of this breakdownCanada: 136 citing papers, 3.4% of this breakdownFrance: 119 citing papers, 3% of this breakdownIndia: 104 citing papers, 2.6% of this breakdownSpain: 101 citing papers, 2.6% of this breakdownGermany: 99 citing papers, 2.5% of this breakdown
0%24.9%Other 28%

Fields

  • Medicine75.3%
  • Biochemistry, Genetics and Molecular Biology11.7%
  • Dentistry4%
  • Immunology and Microbiology1.4%
  • Neuroscience1.2%
  • Agricultural and Biological Sciences1.2%
  • Other5.2%

Topics

  • Oral health in cancer treatment17.1%
  • Head and Neck Cancer Studies8.7%
  • Effects of Radiation Exposure3.5%
  • Salivary Gland Disorders and Functions3.4%
  • Cancer Diagnosis and Treatment3.1%
  • Oral Health Pathology and Treatment2.8%
  • Other61.4%

Coauthors

All papers

Open in search
  1. The pathobiology of mucositis

    Authors: - Nature reviews. Cancer 2004 cited by 1,331

  2. The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies

    Authors: , , , , - CA A Cancer Journal for Clinicians 2021 cited by 230

  3. Perspectives on cancer therapy-induced mucosal injury

    Authors: , , , , , , , , , - Cancer 2004 cited by 1,414

  4. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

    Authors: , , , , , , , , , , , , - Cancer 2014 cited by 1,097

  5. Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yehuda Zadik, René‐Jean Bensadoun, “Cancer Supportive Care” WALT Working Group - Frontiers in Oncology 2022 cited by 164

  6. Cytokine‐mediated blood brain barrier disruption as a conduit for cancer/chemotherapy‐associated neurotoxicity and cognitive dysfunction

    Authors: , , , , , , - International Journal of Cancer 2016 cited by 169

  7. Mucositis: The impact, biology and therapeutic opportunities of oral mucositis

    Authors: - Oral Oncology 2009 cited by 524

  8. New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal Injury

    Authors: , , , , , , , , - Frontiers in Pharmacology 2017 cited by 287

  9. Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 cited by 124

  10. Management of Oral Mucositis in Patients Who Have Cancer

    Authors: , , - Dental Clinics of North America 2008 cited by 606

  11. Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations

    Authors: , , , , , , , , , , , , , , , , , , , , - Supportive Care in Cancer 2016 cited by 261

  12. Pharmacotherapy for the management of cancer regimen-related oral mucositis

    Authors: , - Expert Opinion on Pharmacotherapy 2016 cited by 111

  13. The pathogenesis of mucositis: updated perspectives and emerging targets

    Authors: , , , , , , , , , , , , , , , , , , - Supportive Care in Cancer 2019 cited by 161

  14. Mucositis

    Authors: , - Current Opinion in Oncology 2015 cited by 278

  15. OUP accepted manuscript

    Authors: , , , , , - JNCI Monographs 2019 cited by 94

  16. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis

    Authors: , , , , , , , , , - Cancer 2004 cited by 827

  17. The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: Pathobiology, animal models and cytotoxic drugs

    Authors: , , , , , , - Cancer Treatment Reviews 2007 cited by 277

  18. Phase 1b, multicenter, single blinded, placebo‐controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy

    Authors: , , , , , , , - Cancer 2013 cited by 126

  19. Oral side effects of immune checkpoint inhibitor therapy (ICIT): An analysis of 4683 patients receiving ICIT for malignancies at Massachusetts General Hospital, Brigham & Women's Hospital, and the Dana‐Farber Cancer Institute, 2011 to 2019

    Authors: , , , - Cancer 2021 cited by 53

  20. A hypothesis for the pathogenesis of radiation-induced oral mucositis: when biological challenges exceed physiologic protective mechanisms. Implications for pharmacological prevention and treatment

    Authors: - Supportive Care in Cancer 2021 cited by 44

  21. Oral Mucositis and the Clinical and Economic Outcomes of Hematopoietic Stem-Cell Transplantation

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2001 cited by 683

  22. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma

    Authors: , , , - Cancer 2005 cited by 389

  23. Prediction of mucositis risk secondary to cancer therapy: a systematic review of current evidence and call to action

    Authors: , , , , , , , , , , , - Supportive Care in Cancer 2020 cited by 85

  24. Phase 1b/2a Trial of the Superoxide Dismutase Mimetic GC4419 to Reduce Chemoradiotherapy-Induced Oral Mucositis in Patients With Oral Cavity or Oropharyngeal Carcinoma

    Authors: , , , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2017 cited by 80